Related Experiment Video
Updated: Jul 16, 2026
Simultaneous Imaging of Microglial Dynamics and Neuronal Activity in Awake Mice
Published on: August 23, 2022
[Microglia imaging]
1Department of Brain Sciences and Molecular Imaging, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology.
Abstract:
Imaging of microglia cells using the radiolabeled ligand toward peripheral benzodiazepine receptor(PBR) is applied to brain injury and neurodegenerative diseases. A novel PBR radioligand other than [11C] PK11195 might be desirable to detailedly delineate this complicated phenomenon and a novel idea other than in vitro PBR binding ability is desirable to expect feasibility of a new candidate. Current status, problems and future prospects associated with indirect imaging of microglial activity with [11C] PK11195 will be discussed.
Insights
New radioligands targeting peripheral benzodiazepine receptors (PBR) could improve imaging of microglia cells in brain injuries and neurodegenerative diseases. Further research is needed to develop novel approaches beyond current methods for better diagnostic capabilities.
Area of Science:
- Neuroimaging
- Molecular Imaging
- Radiochemistry
Context:
- Microglia activation is a key factor in brain injury and neurodegenerative diseases.
- Current imaging relies on radiolabeled ligands for peripheral benzodiazepine receptors (PBR).
- [11C] PK11195 is a commonly used PBR ligand but has limitations.
Purpose:
- To discuss the current status, challenges, and future directions of indirect microglial imaging using [11C] PK11195.
- To highlight the need for novel PBR radioligands.
- To explore new strategies for assessing the feasibility of novel PBR imaging agents.
Summary:
- The study reviews the use of PBR radioligands for imaging microglia, crucial in neurological conditions.
- It identifies limitations of the current standard, [11C] PK11195, for detailed microglial activity assessment.
- The need for novel radioligands and assessment methods beyond in vitro binding is emphasized.
Impact:
- Improved diagnostic accuracy for brain injuries and neurodegenerative diseases.
- Development of more effective therapeutic strategies through better disease monitoring.
- Advancement in understanding neuroinflammation and its role in neurological disorders.
More Related Videos
08:17Precise Brain Mapping to Perform Repetitive In Vivo Imaging of Neuro-Immune Dynamics in Mice
Published on: August 7, 2020
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015